Update on ropivacaine

Expert Opinion on Pharmacotherapy

Volumn 2, Issue 12, 2001, Pages 2051-2063

  Wang, R D ^a   Dangler, L A ^a   Greengrass, R A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Local anaesthetic; Pharmacodynamics; Pharmacokinetics; Ropivacaine; Systemic toxicity; Therapeutic applications

Indexed keywords

BUPIVACAINE; ERYTHROMYCIN; ETIDOCAINE; FENTANYL; FLUVOXAMINE; LEVOBUPIVACAINE; LIDOCAINE; LONG ACTING DRUG; MEPIVACAINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ROPIVACAINE; TETRACAINE;

ADULT; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CARDIOTOXICITY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MARKETING; DRUG METABOLISM; DRUG SAFETY; DRUG USE; FEMALE; GASTROINTESTINAL SYMPTOM; HEART DISEASE; HUMAN; LOCAL ANESTHESIA; MALE; MEDICAL PRACTICE; NONHUMAN; OBSTETRIC ANALGESIA; PAIN; PRURITUS; REGIONAL ANESTHESIA; RESUSCITATION; RISK ASSESSMENT; SENSORIMOTOR FUNCTION; TREATMENT OUTCOME; URINE RETENTION;

AMIDES; ANESTHESIA, LOCAL; ANESTHETICS, LOCAL; ANIMALS; CHILD; HUMANS;

EID: 0035205108     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.2.12.2051     Document Type: Article

References (96)

1. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine
2. 1995 Gaston Labat Lecture. Ropivacaine. White knight or dark horse?
3. Ropivacaine
4. Toxicological and local anaesthetic effects of optically active isomers of two local anaesthetic compounds
5. Levobupivacaine: A review of its pharmacology and use as a local anaesthetic
6. Ropivacaine
7. Disposition kinetics of ropivacaine in humans
8. Pharmacokinetics of local anaesthetics
9. Metabolism of a new local anesthetic, ropivacaine, by human hepatic cytochrome P450
10. The effect of erythromycin, fluvoxamine, and their combination on the pharmacokinetics of ropivacaine
11. Alkalinization and precipitation characteristics of 0.2% ropivacaine
12. The effects of ropivacaine hydrochloride on platelet function: An assessment using the platelet function analyser (PFA-100)
13. Ropivacaine: An update of its use in regional anaesthesia
14. Comparative motor-blocking effects of bupivacaine and ropivacaine, a new amino amide local anesthetic, in the rat and dog
15. + channels in rat dorsal root ganglion neurons
16. Comparisons of the anesthetic potency and intracellular concentrations of S(-) and R(+) bupivacaine and ropivacaine in crayfish giant axon in vitro
17. The effect of continuous lumbar epidural infusion of ropivacaine (0.1%, 0.2%, and 0.3%) and 0.25% bupivacaine on sensory and motor block in volunteers: A double-blind study
18. Epidural analgesia with local anesthetics after abdominal surgery: Earlier motor recovery with 0.2% ropivacaine than 0.175% bupivacaine
19. Relative analgesic potencies of ropivacaine and bupivacaine for epidural analgesia in labor: Implications for therapeutic indexes
20. Relative potencies of bupivacaine and ropivacaine for analgesia in labour
21. Ropivacaine, 0.1%, plus sufentanil, 0.5 μg/ ml, versus bupivacaine, 0.1%, plus sufentanil, 0.5 μg/ml, using patient-controlled epidural analgesia for labor: A double-blind comparison
22. Ambulatory labor epidural analgesia: Bupivacaine versus ropivacaine
23. A double-blind comparison of the abdominal wall relaxation produced by epidural 0.75% ropivacaine and 0.75% bupivacaine in gynecologic surgery
24. Equipotency of ropivacaine and bupivacaine in peripheral nerve block
25. Minimum local anesthetic volume blocking the femoral nerve in 50% of cases: A double-blinded comparison between 0.5% ropivacaine and 0.5% bupivacaine
26. Acute toxicity of ropivacaine compared with that of bupivacaine
27. Central nervous and cardiovascular effects of I.V. infusions of ropivacaine, bupivacaine and placebo in volunteers
28. Differences in cardiac toxicity among ropivacaine, levobupivacaine, bupivacaine, and lidocaine
29. Cardiotoxicity with modern local anaesthetics: Is there a safer choice?
30. Actions of three local anaesthetics: Lidocaine, bupivacaine and ropivacaine on guinea pig papillary muscle sodium channels (Vmax)
31. S(-) bupivacaine and RS(±)bupivacaine: A comparison of effects on the right and left atria of the rat
32. Comparative cardiac effect of R(+) and S(-) bupivacaine with (S-) ropivacaine
33. Comparison of the effects of bupivacaine and ropivacaine on heart cell mitochondrial bioenergetics
34. Absence of stereospecific effects of bupivacaine isomers on heart mitochondrial bioenergetics
35. Chronotropic and inotropic effects of ropivacaine, bupivacaine, and lidocaine in the spontaneously beating and electrically paced isolated, perfused rabbit heart
36. Comparative ventricular electrophysiologic effect of racemic bupivacaine, levobupivacaine, and ropivacaine on the isolated rabbit heart
37. Ventricular arrhythmias with or without programmed electrical stimulation after incremental overdosage with lidocaine, bupivacaine, levobupivacaine, and ropivacaine
38. Cardiac resuscitation after incremental overdosage with lidocaine, bupivacaine, levobupivacaine, and ropivacaine in anesthetized dogs
39. Direct cardiac effects of intracoronary bupivacaine, levobupivacaine and ropivacaine in the sheep
40. A comparison of the electrocardiographic cardiotoxic effects of racemic bupivacaine, levobupivacaine, and ropivacaine in anesthetized swine
41. Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog
42. Treatment of acute systemic toxicity after the rapid intravenous injection of ropivacaine and bupivacaine in the conscious dog
43. Milrinone is superior to epinephrine as treatment of myocardial depression due to ropivacaine in pigs
44. Local analgesic and vascular effects of intradermal ropivacaine and bupivacaine in various concentrations with and without addition of adrenaline in man
45. Wound infiltration and drain lavage with ropivacaine after major shoulder surgery
46. The analgesic efficacy of patient-controlled ropivacaine instillation after cesarean delivery
47. Assessment of ropivacaine as a local anesthetic for skin infiltration in skin surgery
48. Comparison of ropivacaine 0.2% and lidocaine 0.5% for intravenous regional anesthesia in volunteers
49. Comparison of ropivacaine and lidocaine for intravenous regional anesthesia in volunteers: A preliminary study on anesthetic efficacy and blood level
50. Intrathecal ropivacaine for ambulatory surgery
51. Intrathecal anesthesia: Ropivacaine versus bupivacaine
52. -1
53. Comparison of 0.5% intrathecal bupivacaine with 0.5% intrathecal ropivacaine in the treatment of refractory cancer and noncancer pain conditions: Results from a prospective, crossover, double-blind, randomized study
54. Transient neurologic symptom (TNS) following intrathecal ropivacaine
55. Ropivacaine plasma concentrations during 120-hour epidural infusion
56. Motor block during patient-controlled epidural analgesia with ropivacaine or ropivacaine/fentanyl after intrathecal bupivacaine for caesarean section
57. Profound motor blockade with epidural ropivacaine following spinal bupivacaine
58. The placental transfer and fetal effects of levobupivacaine, racemic bupivacaine, and ropivacaine
59. Is ropivacaine less potent than bupivacaine?
60. Dose-response study of epidural ropivacaine for labor analgesia
61. Motor blockade is reduced with ropivacaine 0.125% for parturient-controlled epidural analgesia during labour
62. Comparison of three solutions of ropivacaine/fentanyl for postoperative patient-controlled epidural analgesia
63. A comparison of epidural analgesia with 0.125% ropivacaine with fentanyl versus 0.125% bupivacaine with fentanyl during labor
64. Comparison of 1% ropivacaine with 0.75% bupivacaine and 2% lidocaine for peribulbar anaesthesia
65. Ropivacaine for peribulbar anesthesia
66. A prospective randomized double-blinded controlled study of ropivacaine 0.75% versus bupivacaine 0.5%-mepivacaine 2% for peribulbar anesthesia
67. A double-blind randomised comparison of ropivacaine 0.5%, bupivacaine 0.375%-lidocaine 1% and ropivacaine 0.5%-lidocaine 1% mixtures for cataract surgery
68. Peribulbar anesthesia with either 0.75% ropivacaine or a 2% lidocaine and 0.5% bupivacaine mixture for vitreoretinal surgery: A double-blinded study
69. Ropivacaine in peribulbar block: A comparative study with bupivacaine
70. Intraocular pressure and ropivacaine in peribulbar block: A comparative study with bupivacaine
71. A comparison of 0.5% bupivacaine, 0.5% ropivacaine, and 0.75% ropivacaine for interscalene brachial plexus block
72. -1 for supraclavicular brachial plexus anesthesia
73. 0.75% and 0.5% ropivacaine for axillary brachial plexus block: A clinical comparison with 0.5% bupivacaine
74. A comparison of 0.5% ropivacaine and 0.5% bupivacaine for axillary brachial plexus anaesthesia
75. A double-blind comparison of ropivacaine, bupivacaine, and mepivacaine during sciatic and femoral nerve blockade
76. Lumbar plexus and sciatic nerve block for knee arthroplasty: Comparison of ropivacaine and bupivacaine
77. Total knee replacement: A comparison of ropivacaine and bupivacaine in combined femoral and sciatic block
78. The subclavian perivascular technique of brachial plexus anesthesia
79. Continuous regional analgesia: Can we afford not to use it?
80. Patient-controlled interscalene analgesia with ropivacaine after major shoulder surgery: PCIA vs. PCA
81. Patient-controlled interscalene analgesia with ropivacaine 0.2% versus bupivacaine 0.15% after major open shoulder surgery: The effects on hand motor function
82. Brachial plexus infusion of ropivacaine with patient-controlled supplementation
83. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface
84. Caudal anaesthesia with 0.375% ropivacaine or 0.375% bupivacaine in paediatric patients
85. Ropivacaine 0.25% compared with bupivacaine 0.25% by the caudal route
86. Caudal block in children: Ropivacaine compared with bupivacaine
87. The pharmacokinetics of caudal ropivacaine 0.2% in children. A study of infants aged less than 1 year and toddlers aged 1-5 years undergoing inguinal hernia repair
88. Comparison of ropivacaine 0.1% and 0.2% with bupivacaine 0.2% for single-shot caudal anaesthesia in children
89. Pharmacokinetics of ropivacaine following caudal analgesia in children
90. Ropivacaine pharmacokinetics after caudal block in 1-8 year old children
91. Ropivacaine in children
92. Caudal ropivacaine in infants: Population pharmacokinetics and plasma concentrations
93. Pharmacokinetics and clinical efficacy of long-term epidural ropivacaine infusion in children
94. Popliteal fossa block for postoperative analgesia after foot surgery in infants and children